TY - JOUR
T1 - Impaired cardiorespiratory and neuromuscular fitness in children and adolescents with juvenile idiopathic arthritis
T2 - a cross-sectional case–control study in the era of biologic drug therapies
AU - Räsänen, Kati
AU - Markula-Patjas, Kati
AU - Kantanen, Saija
AU - Sipilä, Kalle
AU - Lakka, Timo A.
AU - Arikoski, Pekka
AU - Piippo-Savolainen, Eija
N1 - Funding Information:
We thank all the participating children, adolescents and parents, the staff of the Pediatric Outpatient Clinics in Kuopio and Tampere University Hospitals and the Institute of Biomedicine in the University of Eastern Finland. We also thank the Foundation for Pediatric Research, the Finnish Cultural Foundation, Maire Lisko Foundation, Research Foundation of Rheumatoid diseases and Finnish Sports Academy Foundation for their financial support.
Funding Information:
The study has been financially supported by the Foundation for Pediatric Research, the Finnish Cultural Foundation, Maire Lisko Foundation, Research Foundation of Rheumatoid Diseases and Finnish Sports Academy Foundation (Suomen urheiluopistosäätiö).
Funding Information:
We thank all the participating children, adolescents and parents, the staff of the Pediatric Outpatient Clinics in Kuopio and Tampere University Hospitals and the Institute of Biomedicine in the University of Eastern Finland. We also thank the Foundation for Pediatric Research, the Finnish Cultural Foundation, Maire Lisko Foundation, Research Foundation of Rheumatoid diseases and Finnish Sports Academy Foundation for their financial support.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/3
Y1 - 2023/3
N2 - Background: In recent years, biologic drug therapies have altered the course of juvenile idiopathic arthritis (JIA) possibly also improving the patients’ physical fitness. However, studies measuring both cardiorespiratory and muscular fitness in children with JIA are sparse and have failed to show consistent results. Our aim was to assess both cardiorespiratory and neuromuscular fitness and contributing factors in children and adolescents with JIA in the era of biologic drug therapies. Methods: This cross-sectional study consisted of 73 JIA patients (25 boys, 48 girls) aged 6.8- 17.5 years and 73 healthy age- and sex-matched controls, investigated in 2017–2019. Cardiorespiratory fitness was assessed by maximal ergospirometry and neuromuscular fitness by speed, agility, balance, and muscle strength tests. Results: Means (± SD) of maximal workload (Wmax/kg) and peak oxygen uptake (VO2peak/kg,) were lower in JIA patients than in controls (Wmax/kg: 2.80 ± 0.54 vs. 3.14 ± 0.50 Watts, p < 0.01; VO2peak/kg: 38.7 ± 7.53 vs. 45.8 ± 6.59 ml/min/kg, p < 0.01). Shuttle-run, sit-up and standing long jump test results were lower in JIA patients than in controls (p < 0.01). Mean (± SD) daily activity was lower (89.0 ± 44.7 vs. 112.7 ± 62.1 min/day, p < 0.05), and sedentary time was higher (427 ± 213 vs. 343 ± 211 min/day, p < 0.05) in JIA patients compared to controls. Physical activity and cardiorespiratory or neuromuscular fitness were not associated with disease activity. Conclusions: JIA patients were physically less active and had lower cardiorespiratory and neuromuscular fitness than their same aged controls with no JIA. Therefore, JIA patients should be encouraged to engage in physical activities as a part of their multidisciplinary treatment protocols to prevent adverse health risks of low physical activity and fitness.
AB - Background: In recent years, biologic drug therapies have altered the course of juvenile idiopathic arthritis (JIA) possibly also improving the patients’ physical fitness. However, studies measuring both cardiorespiratory and muscular fitness in children with JIA are sparse and have failed to show consistent results. Our aim was to assess both cardiorespiratory and neuromuscular fitness and contributing factors in children and adolescents with JIA in the era of biologic drug therapies. Methods: This cross-sectional study consisted of 73 JIA patients (25 boys, 48 girls) aged 6.8- 17.5 years and 73 healthy age- and sex-matched controls, investigated in 2017–2019. Cardiorespiratory fitness was assessed by maximal ergospirometry and neuromuscular fitness by speed, agility, balance, and muscle strength tests. Results: Means (± SD) of maximal workload (Wmax/kg) and peak oxygen uptake (VO2peak/kg,) were lower in JIA patients than in controls (Wmax/kg: 2.80 ± 0.54 vs. 3.14 ± 0.50 Watts, p < 0.01; VO2peak/kg: 38.7 ± 7.53 vs. 45.8 ± 6.59 ml/min/kg, p < 0.01). Shuttle-run, sit-up and standing long jump test results were lower in JIA patients than in controls (p < 0.01). Mean (± SD) daily activity was lower (89.0 ± 44.7 vs. 112.7 ± 62.1 min/day, p < 0.05), and sedentary time was higher (427 ± 213 vs. 343 ± 211 min/day, p < 0.05) in JIA patients compared to controls. Physical activity and cardiorespiratory or neuromuscular fitness were not associated with disease activity. Conclusions: JIA patients were physically less active and had lower cardiorespiratory and neuromuscular fitness than their same aged controls with no JIA. Therefore, JIA patients should be encouraged to engage in physical activities as a part of their multidisciplinary treatment protocols to prevent adverse health risks of low physical activity and fitness.
KW - Cardiorespiratory fitness
KW - Disease activity
KW - Juvenile idiopathic arthritis
KW - Neuromuscular fitness
KW - Physical activity
U2 - 10.1186/s12969-023-00808-9
DO - 10.1186/s12969-023-00808-9
M3 - Article
C2 - 36932386
AN - SCOPUS:85150665782
SN - 1546-0096
VL - 21
JO - PEDIATRIC RHEUMATOLOGY
JF - PEDIATRIC RHEUMATOLOGY
M1 - 26
ER -